Skip to main content
Log in

Purification and Characterization of a Novel Heparin Degrading Enzyme from Aspergillus flavus (MTCC-8654)

  • Published:
Applied Biochemistry and Biotechnology Aims and scope Submit manuscript

Abstract

A heparinase-producing fungus was isolated, and the strain was taxonomically characterized as Aspergillus flavus by morphophysiological and 26S rRNA gene homology studies. The culture produced intracellular heparinase enzyme, which was purified 40.5-fold by DEAE-Sephadex A-50, CM-Sephadex C-50, and Sephadex G-100 column chromatography. Specific activity of the purified enzyme was found to be 44.6 IU/μg protein and the molecular weight of native as well as reduced heparinase was 24 kDa, showing a monomeric unit structure. Peptide mass spectrum showed poor homogeneity with the database in the peptide bank. The enzyme activity was maximum at 30 °C in the presence of 300 mM NaCl at pH 7.0. In the presence of Co2+, Mn2+ ions, and reducing agents (β-mercaptoethanol, dithiothreitol), enzyme activity was enhanced and inhibited by iodoacetic acid. These observations suggested that free sulfohydryl groups of cysteine residues were necessary for catalytic activity of the enzyme. The enzyme was also inhibited by histidine modifier, DEPC, which suggests that along with cysteine, histidine may be present at its active site. The enzyme showed a high affinity for heparin as a substrate with K m and V max as 2.2 × 10−5 M and 30.8 mM min−1, respectively. The affinity of the enzyme for different glycosaminoglycans studied varied, with high substrate specificity toward heparin and heparin-derived polysaccharides. Depolymerization of heparin and fractionation of the oligosaccharides yielded heparin disaccharides as main product.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Linhardt, R. J., & Gunay, N. S. (1999). Seminars in Thrombosis and Hemostasis, 25(Suppl 3), 5–16. doi:10.1055/s-2007-996417.

    CAS  Google Scholar 

  2. Segal, J. B., Eng, J., Jenckes, M. W., Tamariz, L. J., Bolger, D. T., Krishnan, J. A., et al. (2003). Evidence Report/Technology Assessment (Summary)1–6.

  3. Yoshida, E., Sakai, K., Tokuyama, S., Miyazono, H., Maruyama, H., Morikawa, K., et al. (2002). Bioscience, Biotechnology, and Biochemistry, 66, 1181–1184. doi:10.1271/bbb.66.1181.

    Article  CAS  Google Scholar 

  4. Kim, W. S., Kim, B. T., Kim, D. H., & Kim, Y. S. (2004). Journal of Biochemistry and Molecular Biology, 37, 684–690.

    CAS  Google Scholar 

  5. Yapeng, C., Ningguo, G., Xiulan, C., Jing, Y., Shijun, Q., & Shuzheng, Z. (2003). Journal of Biochemistry, 134, 365–371. doi:10.1093/jb/mvg154.

    Article  Google Scholar 

  6. Zimmerman, J., Lewis, N., & Heft, R.(1993) Method for the enzymatic neutralization of heparin, US Patent 5,262,325.

  7. van den Besselaar, A. M., & Meeuwisse-Braun, J. (1993). Blood Coagulation & Fibrinolysis, 4, 635–638. doi:10.1097/00001721-199308000-00016.

    Article  Google Scholar 

  8. Dongfang, L., Pojasek, K., Shriver, Z., Holley, K., El-shabrawi, Y., Venkataraman, G., et al. (2002) Heparinase III and uses thereof, EP Patent 1,266,013.

  9. Sasisekharan, R., Moses, M. A., Nugent, M. A., Cooney, C. L., & Langer, R. (1994). Proceedings of the National Academy of Sciences of the United States of America, 91, 1524–1528. doi:10.1073/pnas.91.4.1524.

    Article  CAS  Google Scholar 

  10. Shaya, D., Tocilj, A., Li, Y., Myette, J., Venkataraman, G., Sasisekharan, R., et al. (2006). The Journal of Biological Chemistry, 281, 15525–15535. doi:10.1074/jbc.M512055200.

    Article  CAS  Google Scholar 

  11. Joubert, J., & Pitout, M. (1985). Cellular and Molecular Life Sciences, 41, 1541.

    Article  CAS  Google Scholar 

  12. Zimmermann, J., Su, H., Blain, F., Bennett, C., Gu, K., & Musil, R.(2003) Nucleic acid sequences and expression systems for heparinase III derived from flavobacterium heparinum, EP Patent 0,763,101.

  13. Varga, J., Juhász, Á., Kevei, F., & Kozakiewicz, Z. (2004). European Journal of Plant Pathology, 110, 627–640. doi:10.1023/B:EJPP.0000032402.36050.df.

    Article  CAS  Google Scholar 

  14. Banga, J., Tripathi, C. K. M., & Bihari, V. (2008). Medicinal Chemistry Research, 17, 85–93. doi:10.1007/s00044-007-9039-2.

    Article  CAS  Google Scholar 

  15. Linker, A., & Hovingh, P. (1972). In U. Ginsburg (Ed.), Methods in enzymology, vol. 28: Heparinase and heparitinase from flavo-bacteria. (pp 902–911). New York: Academic.

    Google Scholar 

  16. Lohse, D., & Linhardt, R. (1992). The Journal of Biological Chemistry, 267, 24347–24355.

    CAS  Google Scholar 

  17. Rosenfeld, J., Capdevielle, J., Guillemot, J. C., & Ferrara, P. (1992). Analytical Biochemistry, 203, 173–179. doi:10.1016/0003-2697(92)90061-B.

    Article  CAS  Google Scholar 

  18. Gao, J., Liu, Z., & Yu, J. (2007). Mycopathologia, 164, 91–95. doi:10.1007/s11046-007-9029-4.

    Article  Google Scholar 

  19. Nikkuni, S., Nakajima, H., Hoshina, S. I., Ohno, M., Suzuki, C., Kashiwagi, Y., et al. (1998). The Journal of General and Applied Microbiology, 44, 225–230. doi:10.2323/jgam.44.225.

    Article  CAS  Google Scholar 

  20. Sasisekharan, R., Lohse, D., Cooney, C., Linhardt, R., & Langer, R.(1996) Purification, composition and specificity of heparinase I, II, and III from flavobacterium heparinum, US Patent 5, 569, 600.

    Google Scholar 

  21. Bohmer, L. H., Pitout, M. J., Steyn, P. L., & Visser, L. (1990). The Journal of Biological Chemistry, 265, 13609–13617.

    CAS  Google Scholar 

  22. Ernst, S., Langer, R., Cooney, C. L., & Sasisekharan, R. (1995). Critical Reviews in Biochemistry and Molecular Biology, 30, 387–444. doi:10.3109/10409239509083490.

    Article  CAS  Google Scholar 

  23. Godavarti, R., & Sasisekharan, R. (1998). The Journal of Biological Chemistry, 273, 248–255. doi:10.1074/jbc.273.1.248.

    Article  CAS  Google Scholar 

  24. Shriver, Z., Hu, Y., Pojasek, K., & Sasisekharan, R. (1998). The Journal of Biological Chemistry, 273, 22904–22912. doi:10.1074/jbc.273.36.22904.

    Article  CAS  Google Scholar 

  25. Viskov, C., & Mourier, P. (2007) Oligosaccharides, preparation method and use thereof, and pharmaceutical compositions containing same, US patent 0, 142, 323.

  26. Yamada, S., & Sugahara, K. (2003). In P. Thibault, & S. Honda (Eds.),Methods in molecular biology vol. 213: Preparation of oligosaccharides from sulfated glycosaminoglycans using bacterial enzymes (pp. 71–78). Clifton, NJ: Humana.

    Google Scholar 

Download references

Acknowledgement

This research was financially supported by grant from University Grants Commision, South Campus, Delhi University, Benito Juarez Marg, New Delhi-110021.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C. K. M. Tripathi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Banga, J., Tripathi, C.K.M. Purification and Characterization of a Novel Heparin Degrading Enzyme from Aspergillus flavus (MTCC-8654). Appl Biochem Biotechnol 160, 1004–1016 (2010). https://doi.org/10.1007/s12010-009-8530-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12010-009-8530-2

Keywords

Navigation